215 related articles for article (PubMed ID: 20004218)
1. Early behavioural markers of disease in P301S tau transgenic mice.
Scattoni ML; Gasparini L; Alleva E; Goedert M; Calamandrei G; Spillantini MG
Behav Brain Res; 2010 Mar; 208(1):250-7. PubMed ID: 20004218
[TBL] [Abstract][Full Text] [Related]
2. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.
Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M
Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267
[TBL] [Abstract][Full Text] [Related]
3. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
[TBL] [Abstract][Full Text] [Related]
4. Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury.
Xu L; Ryu J; Nguyen JV; Arena J; Rha E; Vranis P; Hitt D; Marsh-Armstrong N; Koliatsos VE
Exp Neurol; 2015 Nov; 273():168-76. PubMed ID: 26311071
[TBL] [Abstract][Full Text] [Related]
5. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
[TBL] [Abstract][Full Text] [Related]
6. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
Kreilaus F; Masanetz R; Watt G; Przybyla M; Ittner A; Ittner L; Karl T
Behav Brain Res; 2021 Jan; 397():112943. PubMed ID: 33017638
[TBL] [Abstract][Full Text] [Related]
7. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.
Gasparini L; Crowther RA; Martin KR; Berg N; Coleman M; Goedert M; Spillantini MG
Neurobiol Aging; 2011 Mar; 32(3):419-33. PubMed ID: 19356824
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.
Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG
Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
[TBL] [Abstract][Full Text] [Related]
10. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
[TBL] [Abstract][Full Text] [Related]
11. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
12. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
13. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
Ahmad F; Mein H; Jing Y; Zhang H; Liu P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
[TBL] [Abstract][Full Text] [Related]
14. 3R tau expression modifies behavior in transgenic mice.
Shiryaev N; Jouroukhin Y; Gozes I
J Neurosci Res; 2010 Sep; 88(12):2727-35. PubMed ID: 20544828
[TBL] [Abstract][Full Text] [Related]
15. Progressive tauopathy in P301S tau transgenic mice is associated with a functional deficit of the olfactory system.
Yang S; Kuan WL; Spillantini MG
Eur J Neurosci; 2016 Sep; 44(6):2396-403. PubMed ID: 27422327
[TBL] [Abstract][Full Text] [Related]
16. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
17. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
[TBL] [Abstract][Full Text] [Related]
18. GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.
Santa-Maria I; Diaz-Ruiz C; Ksiezak-Reding H; Chen A; Ho L; Wang J; Pasinetti GM
Neurobiol Aging; 2012 Sep; 33(9):2072-81. PubMed ID: 22054871
[TBL] [Abstract][Full Text] [Related]
19. Zinc Exacerbates Tau Pathology in a Tau Mouse Model.
Craven KM; Kochen WR; Hernandez CM; Flinn JM
J Alzheimers Dis; 2018; 64(2):617-630. PubMed ID: 29914030
[TBL] [Abstract][Full Text] [Related]
20. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]